argenx SE American Depositary Receipt (1AEA)
FSX
Real-time Data
06:00 AM
Day's Range
875.0052 wk Range
560.00Overview - 1AEA - argenx SE American Depositary Receipt
Key Statistics
Valuation
Enterprise Value
1.16T
P/E (Trailing)
‪38.90‬
P/E (Forward)
‪-55.17‬
PEG Ratio
‪-55.17‬
Price / Sales (TTM)
‪10.23‬
Price / Book
‪189.95‬
EV / EBITDA
‪844.98‬
Profitability
Gross Margin
‪90.42%‬
Profit Margin
‪32.26%‬
Operating Margin
‪31.99%‬
Return on Assets
‪11.63%‬
Return on Equity
‪23.63%‬
Ownership
Shares Outstanding
62.53M
Float
1.56B
Held by Insiders
‪0.00%‬
Held by Institutions
‪46.20%‬
Price stats
Beta
‪-0.04‬
50-Day Avg
‪766.30‬
200-Day Avg
‪709.08‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1AEA - argenx SE American Depositary Receipt
Peers - 1AEA - argenx SE American Depositary Receipt
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
- 22UAFSXBioNTech SE25.39BMarket Cap+9.15%52-week change157.87P/E (Trailing)‪-63.63%‬Profit Margin
Profile Summary - 1AEA - argenx SE American Depositary Receipt
About
argenx SE is a global, commercial-stage biopharmaceutical company headquartered in Amsterdam, Netherlands, specializing in antibody-based therapies for severe autoimmune diseases. The company developed and commercializes VYVGART (efgartigimod), the first approved neonatal Fc receptor (FcRn) blocker, which is now…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
